Registrar Corp Registrar Corp LinkedIn Registrar Corp Twitter Registrar Corp Facebook Registrar Corp Google+ Registrar Corp Youtube Channel Registrar Corp FDA News Blog
HomeDrugsU.S. FDA Active Pharmaceutical Ingredients (API)API Examples › U.S. FDA Regulations: Quinapril Hydrochloride

U.S. FDA Requirements: Quinapril Hydrochloride

Pharmaceutical / Drug Definition : Inhibits conversion of angiotensin I to angiotensin II, a potent vasoconstrictor; decreases cardiac output. Increases plasma renin levels and reduces aldosterone levels, causing systemic vasodilation.

Registrar Corp assists Quinapril Hydrochloride companies with:

  • FDA Registration Quinapril Hydrochloride
  • FDA Listing Quinapril Hydrochloride
  • FDA Label Requirements and Exceptions Quinapril Hydrochloride
  • FDA Import Information Quinapril Hydrochloride
  • FDA Detentions Quinapril Hydrochloride (Quinapril Hydrochloride Entry Refusal)
  • General U.S. Food and Drug Administration Guidelines for:
       - Manufacturers Quinapril Hydrochloride (Quinapril Hydrochloride Suppliers)
       - Processors Quinapril Hydrochloride
       - Repackers Quinapril Hydrochloride
       - Relabelers Quinapril Hydrochloride
       - Exporters Quinapril Hydrochloride
       - Importers Quinapril Hydrochloride
For more information about Quinapril Hydrochloride, simply click below:




Live Help

 
U.S. FDA Regulations:

U.S. FDA Regulation: 21 C.F.R. Part 207


Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
Home | About Us | News | Resources | Exhibitions | Seminars | Associations | Careers | Sitemap | Terms of Use © 2014 Registrar Corp
 
Food and Beverages | Drugs | Cosmetics | Medical Devices | Radiation-Emitting Electronic Devices | Color Additives | Tobacco